DA32 Life Science Tech Acquisition Corp.

DA32 Life Science Tech Acquisition Corp. (Nasdaq: DALS) is a blank-check company formed to pursue a business combination in the life science and technology sector. The company completed its initial public offering in 2021 and filed a Form 10-Q with the U.S. Securities and Exchange Commission on May 13, 2022, under accession number 0001193125-22-150065, documenting its financial position during the active search phase. DALS entered the market as part of a broader wave of sector-focused SPACs targeting healthcare and biotechnology innovation during a period of elevated blank-check activity. The quarterly filing reflects the company's status as an ongoing blank-check vehicle awaiting a qualifying business combination target. For the complete filing history, deal timeline, and sponsor profile on DALS, sign up for full data access at SpacDesk.